PMV Pharmaceuticals Inc is a precision oncology company... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BTR | 25.59 | N/A | N/A |
| Beacon Tactical Risk ETF (BTR) | |||
| LFAO | 154.56 | N/A | N/A |
| LifeX 2055 Longevity Income ETF (LFAO) | |||
| TSMY | 15.76 | -0.05 | -0.32% |
| YieldMax TSM Option Income Strategy ETF (TSMY) | |||
| GEM | 50.93 | -0.17 | -0.33% |
| Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) | |||
| AVSD | 78.77 | -0.89 | -1.12% |
| Avantis Responsible International Equity ETF (AVSD) | |||
A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.
| Ticker / NAME | Correlation To PMVP | 1D Price Change % | ||
|---|---|---|---|---|
| PMVP | 100% | +4.79% | ||
| CLLS - PMVP | 39% Loosely correlated | -7.28% | ||
| MTVA - PMVP | 35% Loosely correlated | -1.91% | ||
| AXON - PMVP | 31% Poorly correlated | -0.07% | ||
| ARRY - PMVP | 31% Poorly correlated | -3.47% | ||
| VCYT - PMVP | 30% Poorly correlated | -4.02% | ||
More | ||||
The 50-day moving average for PMVP moved above the 200-day moving average on September 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on September 29, 2026. You may want to consider a long position or call options on PMVP as a result. In 84 of 111 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for PMVP just turned positive on September 30, 2026. Looking at past instances where PMVP's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.
PMVP moved above its 50-day moving average on September 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +22.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where PMVP advanced for three days, in 199 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 94 of 112 cases where PMVP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMVP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
PMVP broke above its upper Bollinger Band on September 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. PMVP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.017) is normal, around the industry mean (26.780). P/E Ratio (6.180) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMVP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.